BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30657113)

  • 1. A review on role of ATM gene in hereditary transfer of colorectal cancer.
    Sriramulu S; Ramachandran M; Subramanian S; Kannan R; Gopinath M; Sollano J; Bissi L; Banerjee A; Marotta F; Pathak S
    Acta Biomed; 2019 Jan; 89(4):463-469. PubMed ID: 30657113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
    Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
    Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer.
    Maillet P; Chappuis PO; Vaudan G; Dobbie Z; Müller H; Hutter P; Sappino AP
    Int J Cancer; 2000 Dec; 88(6):928-31. PubMed ID: 11093816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
    Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
    Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
    J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
    Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
    Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
    Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic features of International Collaborative Group-hereditary nonpolyposis colorectal cancer families and suspected hereditary nonpolyposis colorectal cancer families.
    Yuan Y; Ye J; Zheng S;
    Chin Med J (Engl); 2004 May; 117(5):748-52. PubMed ID: 15161546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
    Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.
    Thompson E; Meldrum CJ; Crooks R; McPhillips M; Thomas L; Spigelman AD; Scott RJ
    Clin Genet; 2004 Mar; 65(3):215-25. PubMed ID: 14756672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in patient management. Hereditary colorectal cancers].
    Lakatos PL; Lakatos L
    Orv Hetil; 2006 Feb; 147(8):363-8. PubMed ID: 16579336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
    Hegde MR; Roa BB
    Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
    Kouraklis G; Misiakos EP
    Dig Dis Sci; 2005 Feb; 50(2):336-44. PubMed ID: 15745097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.